How to Build a High-Value Biopharma Consulting Firm Through Commercial Excellence With Gregory Lief

Look into the "3 Ways to Generate Leads With Your Podcast" E-book for free here on our website! (https://ghapodcast.com)

Want to solve Branding and Lead-Gen for good for your B2B Business? Download our Completed Playbook for FREE: https://ghapodcast.com/b2b-podcasting-secrets-pod

**********************************************************************

Gregory Lief operates at the intersection of strategy and execution in biopharma. After leading Global Commercial Excellence & Operations at Biogen, reporting to the Chief Commercial Officer, he founded Asymmetry Group to help emerging healthcare companies make the leap from science-driven organizations to commercially disciplined businesses. His work spans corporate strategy, launch planning, marketing and sales operations, forecasting, and capability development. What makes Greg’s perspective different is that he’s built these systems inside large global organizations and now translates that experience into advisory support for high-growth life sciences firms.

For consulting firm owners, this conversation is about leverage: how to move from insight to infrastructure, how to design governance that scales, and why asymmetric thinking, not benchmarking to the average, drives durable advantage.

**********************************************************

Proposed Interview Structure:

1. Greg, you’ve led strategy and commercial operations inside major biotech organizations. What originally pulled you into consulting and commercial strategy within healthcare?

2. What specific problem are you solving today with Asymmetry Group when a biopharma company calls you, and why is that transition from development-stage to commercial-stage so difficult?

3. Who are your ideal clients right now? Are you working primarily with venture-backed biotech, mid-size pharma, or more established players, and who is usually the decision maker?

4. In such a specialized industry, how do clients typically find you? What has worked best to attract the right kind of engagements? Current Acquisition Channels: Referral, Content Sub Question: What’s your perspective on podcasting as a marketing tool in the biopharma or life sciences consulting space?

5. Given the long, complex buying cycles in biotech, multiple stakeholders, scientific scrutiny, budget approvals, how do you typically move from first conversation to signed engagement?

6. How do you retain clients over the long term, and what do you do deliberately to ensure they keep coming back and see you as a trusted partner rather than a one-off advisor?

7. Where do you find yourself most stuck right now as a consulting firm founder in the biopharma space (if at all)?

8. Looking ahead, where do you see the biggest opportunity for commercialization strategy and launch excellence in biopharma over the next few years?

*********************************************************************

Know more about Gregory Lief

Website Link: https://asymmetrygroup.com/

Connect with Gregory Lief on LinkedIn

LinkedIn link: https://www.linkedin.com/in/gregorylief/

Apply to be a guest on Consulting Leaders:

https://ghapodcast.com/application-to-be-a-guest-on-consulting-leaders/